Resources from the same session
1076 - MONARCHplus: A Phase 3 Trial of Abemaciclib plus Nonsteroidal Aromatase Inhibitor (NSAI) or Fulvestrant (F) for Women with HR+/HER2- Advanced Breast Cancer (ABC)
Presenter: Zefei Jiang
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract